Dietzen D J, Koenig J, Turk J
Drug Analysis Laboratory, Barnes Hospital, Washington University School of Medicine, St. Louis, MO 63110, USA.
J Anal Toxicol. 1995 Sep;19(5):299-303. doi: 10.1093/jat/19.5.299.
Qualitative identification of opiates in urine is commonly achieved in two stages, the first involving immunoassay screening and the second involving chromatographic confirmation. Identification of specific opiates is often requested to determine whether the source of opiates is from diet, prescription pharmaceuticals, or illicit drugs. During evaluation of the Toxi-Lab thin-layer chromatographic system as a confirmatory technique for urinary opiates, we encountered difficulty distinguishing opiates with similar retention factor values and colorimetric behavior. By exploiting chemical differences of the comigrating opiates through preparation of acetate or methoxime derivatives, followed by chromatography of the underivatized and derivatized samples in adjacent lanes, we were able to more easily distinguish codeine from hydrocodone, 6-acetylmorphine from oxymorphone, and dihydrocodeine from hydromorphone.
尿液中阿片类药物的定性鉴定通常分两个阶段进行,第一阶段涉及免疫分析筛查,第二阶段涉及色谱确认。通常需要鉴定特定的阿片类药物,以确定阿片类药物的来源是饮食、处方药物还是非法药物。在评估Toxi-Lab薄层色谱系统作为尿液中阿片类药物的确证技术时,我们在区分具有相似保留因子值和比色行为的阿片类药物时遇到了困难。通过制备乙酸酯或甲氧肟衍生物来利用共迁移阿片类药物的化学差异,然后在相邻泳道中对未衍生化和衍生化的样品进行色谱分析,我们能够更轻松地区分可待因与氢可酮、6-乙酰吗啡与羟吗啡酮以及二氢可待因与氢吗啡酮。